Explore our leading OEM/ODM clinical diagnostic systems, customized imaging systems, and core healthcare hardware engineered to maximize diagnostic accuracy and institutional reliability.
Countries Supplied Worldwide
Certified Quality System
Traceable Reagent & Hardware Pipeline
Flexible Design & Manufacturing
The modern medical diagnostic industry is undergoing a paradigm shift characterized by the transition from generic hardware to software-defined imaging modalities and integrated biological screening systems. Emerging technologies such as Artificial Intelligence (AI) edge reconstruction, cloud-connected telemedicine interfaces, and ultra-high-resolution imaging sensors are reshaping B2B healthcare procurement paradigms.
Medical establishments and global distributors are seeking more than off-the-shelf catalog products. The primary requirement has pivoted towards integrated diagnostic architectures where hardware performance, such as full-digital ultrasonic imaging or multichannel PCR, is seamlessly synchronized with customizable diagnostic assays, antibodies, and reliable clinical test reagents.
We combine advanced hardware development with a robust biotechnology pipeline, providing complete vertical integration from basic biomolecules to comprehensive diagnostic hardware.
We manufacture antigens, antibodies, and diagnostic assays in-house, pairing them with custom-engineered medical diagnostic systems to ensure optimized clinical performance.
Our operations align with global medical device standards, emphasizing human rights, resource efficiency, and local compliance certification support (CE, ISO 13485, FDA guidance).
With clinical products actively used in over 60 countries, our logistics network and supply-chain structures guarantee prompt delivery and continuous technical maintenance.
Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. Our comprehensive product pipeline covers key medical sectors including cardiovascular and cerebrovascular conditions, systemic inflammation, infectious diseases, oncology, hormonal assays, and specialized veterinary diagnostics. We control the process from raw materials to final finished products.
Innovation is in our DNA. Bioantibody consistently develops and patents new technology platforms. Currently, our diagnostic products and medical solutions have been successfully delivered to more than 60 countries and cities worldwide. Operating under a strict ISO 13485 management system, our product quality is trusted by clinical laboratories, hospitals, and medical research institutes globally.
Aligned with our core mission, "Biotech For A Better Life", we focus on medical innovation to deliver dependable diagnostic systems to our customers. We strive to contribute to human health, environmental safety, and global healthcare equity by offering affordable, reliable, and accessible biotechnological solutions.
Select specialized diagnostic systems, full-digital imaging equipment, and biochemical preparation systems designed for clinical hospitals and research facilities.
Helping hospitals, labs, and OEM partners address supply chain bottlenecks, regulatory standards, and complex integration requirements.
Medical imaging systems, such as full-digital veterinary and clinical ultrasound machines or brain mapping electroencephalograms (EEG), demand strict signal integrity, low signal-to-noise ratios, and reliable performance. Our manufacturing facility works with partner designers to customize transducer assemblies, analog-to-digital processing boards, and user software interfaces. This ensures full compliance with localized electro-magnetic compatibility (EMC) regulations, including IEC 60601-1-2 standards.
A frequent challenge for IVD manufacturers is the performance mismatch between diagnostic instruments and biological reagents. Because we design and synthesize our own antibodies and detection reagents (focused on inflammation markers, tumor antigens, and hormone panels), we calibrate the optoelectronic detectors on our molecular PCR analyzers and 3-part hematology systems directly against the target biological assays. This unified calibration minimizes background noise and improves diagnostic specificity.
Modern clinical hubs require energy-efficient operations. By integrating high-power, quiet-running backup generators (such as 780kVA units) and low-energy medical diagnostics, we support facilities in maintaining continuous operation during grid instability. Additionally, our manufacturing processes prioritize ethical material selection, reduced toxic chemical outputs, and recyclable packaging, aligning with modern corporate environmental requirements.
Entering international healthcare markets requires extensive documentation. We provide OEM/ODM partners with structured technical dossiers, including biocompatibility reports, clinical trial performance data, validation files, and safety certificates. This speeds up the registration process with regulatory bodies such as the FDA, EMA, and national health authorities.
Our long-term R&D plan focuses on smart technology, portable designs, and clinical accessibility.
Deploying integrated neural processor units (NPU) into clinical diagnostic and karyotyping platforms to automate cell classification, lesion identification, and real-time noise filtration.
Downsizing bulky real-time PCR systems into integrated microfluidic cartridges, allowing rapid molecular confirmation of infectious diseases within minutes at the point of care.
Connecting medical-grade wearables, like screenless biometric bands, to centralized clinical databases to provide longitudinal health tracking and early alert systems.
Get answers to common questions about our OEM/ODM capabilities, manufacturing capacity, regulatory compliance, and ordering processes.
Medvok Medical
